Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy

• Mary Beth Yacyshyn, PhD,
• James Collins, PhD,
• Michelle Chua, PhD,
• Angela Siegwald, MSN,
• Sara Yacyshyn, MD,
• Valerie Briones-Pryor, MD,
• Bruce Yacyshyn, MD

Affiliations

Mary Beth Yacyshyn, PhD

Musidora Biotechnology LLC, Cincinnati, Ohio

James Collins, PhD

Department of Microbiology & Immunology, University of Louisville, Louisville, Kentucky

Michelle Chua, PhD

Department of Microbiology & Immunology, University of Louisville, Louisville, Kentucky

Angela Siegwald, MSN

Division of Gastroenterology, Hepatology, and Nutrition, University of Louisville School of Medicine, Louisville, Kentucky

Sara Yacyshyn, MD

Digestive Diseases & Surgery Institute, Cleveland Clinic, Cleveland, Ohio

Valerie Briones-Pryor, MD

University of Louisville Health, Louisville, Kentucky

Bruce Yacyshyn, MD

Medpace Inc, Cincinnati, Ohio; Corresponding author: